# Minnow Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/minnow-medical

- Industry: Medical Devices & Equipment
- Headquarters: Laguna Hills, US
- Website: www.minnowmedical.com
- Total disclosed funding: $23M
- Latest round: Series B (Aug 3, 2011)
- Investors on record: 6

## About

Minnow Medical is dedicated to enhancing the healthcare industry by providing a valuable domain name tailored for medical and healthcare businesses, aimed at improving their online visibility.Minnow Medical specializes in the medical and healthcare sectors, focusing on offering a premium domain name to enhance online presence for its clients. The company is headquartered in Laguna Hills, US. In November 2012, Boston Scientific acquired Vessix Vascular, the parent company of Minnow Medical, for USD 425 million, with potential additional payments based on clinical and sales targets. The founder's detailed history is currently not specified.MinnowMedical.com specializes in providing a premium domain name for sale, specifically targeting businesses and individuals in the medical and healthcare sectors. The core offering, 'MinnowMedical.com', is strategically positioned to serve a variety of end-users including healthcare providers, medical startups, and professionals seeking to establish a robust online presence in the medical field. This domain aims to facilitate brand recognition and marketing in a competitive industry, appealing primarily to English-speaking countries with developed healthcare systems.Revenue generation for MinnowMedical.com is derived from the sale of the domain name, priced at USD 2,995, with an option for a payment plan of USD 124.79 per month over 24 months. The primary transaction structure involves direct sales to individual clients or businesses looking to purchase the domain outright or through financing options. This pricing strategy allows for flexible purchasing options, catering to a diverse client base in the healthcare sector.The company plans to leverage the successful acquisition by Boston Scientific to enhance its market presence. Although specific upcoming products are not detailed, the acquisition funding will likely support marketing initiatives aimed at expanding into new geographical regions, particularly targeting developed healthcare markets by 2017. This strategic shift follows the recent acquisition deal concluded in November 2012, where Boston Scientific committed to significant financial incentives based on performance targets.

## Funding rounds

- Series B, Aug 3, 2011, $23M — OrbiMed Advisors, Andera Partners, NeoMed, Fjord Invest, CWC HealthTech Advisors, DNV Capital

## Investors

- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series B
- NeoMed (https://capitalatlas.ai/funds/neomed) — Series B
- Fjord Invest (https://capitalatlas.ai/funds/fjord-invest) — Series B
- CWC HealthTech Advisors (https://capitalatlas.ai/funds/cwc-healthtech-advisors) — Series B
- DNV Capital (https://capitalatlas.ai/funds/dnv-capital) — Series B